MEDF — Medfield Diagnostics AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK17.06m
- SEK9.95m
- SEK0.71m
Annual cashflow statement for Medfield Diagnostics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.08 | -7.26 | -7.26 | -8.38 | -13.9 |
| Depreciation | |||||
| Non-Cash Items | 1.28 | -0.625 | — | 0.01 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.49 | -2.59 | -0.449 | -2.57 | -0.037 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.15 | -10.4 | -7.71 | -10.9 | -12.3 |
| Capital Expenditures | -6.33 | -6.32 | -7.6 | -7.09 | -6.47 |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.463 | -0.299 | -0.002 | 0 | — |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.79 | -6.62 | -7.6 | -7.09 | -6.47 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 21.8 | 5.01 | 18.8 | 17.7 | 16.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.9 | -12 | 3.48 | -0.358 | -2.59 |